CytoMed Therapeutics Limited GDTC
0.77 USD -0.06 (-6.87%)
Regular-session close
0.77 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
0.73 Day range 0.8499
0.68 52-week range 2.12
- YTD
- -42.31%
- 1 year
- -57.29%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 324.39K | 69.50K | 0 | 0 | 0 | |
| 324.39K | 69.50K | 0 | 0 | 0 | |
| -2.44M | -1.81M | -1.34M | -1.36M | -1.20M | |
| -3.98M | -2.52M | -4.13M | -3.13M | -2.05M | |
| -0.34 | -0.22 | -0.39 | -0.40 | -0.30 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.10M | 4.97M | 9.00M | 1.58M | 2.51M | |
| 7.98M | 10.07M | 12.37M | 5.23M | 6.08M | |
| 1.13M | 1.02M | 1.12M | 4.64M | 3.49M | |
| 482.56K | 463.25K | 448.02K | 4.22M | 3.26M | |
| 6.54M | 8.97M | 11.25M | 586.98K | 2.59M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -3.70M | -2.71M | -3.53M | -1.40M | -1.72M | |
| 929.28K | 1.13M | -2.73M | -473.31K | -823.67K | |
| 208.65K | -64.89K | 10.92M | 968.72K | 4.17M | |
| -637.85K | -1.40M | -58.30K | -473.31K | -582.35K | |
| -2.56M | -1.65M | 4.66M | -903.00K | 1.64M |
